Royal DSM, the global Life Sciences and Materials Sciences company, has repurchased 217,727 of its own shares in the period from 6 November 2013 up to and including 14 November 2013 at an average price of €58.05.
This is in accordance with the repurchase, covering existing option plans, announced on 6 November 2013. The consideration of this repurchase was €12.6 million.
